We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

44 hedge funds and large institutions have $7.65M invested in BioPlus Acquisition Corp. Warrants in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

156% more capital invested

Capital invested by funds: $2.99M → $7.65M (+$4.66M)

10% less funds holding

Funds holding: 4944 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.71%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
8
Calls
$1.97M
Puts
Net Calls
+$1.97M
Net Calls Change
+$13K
Name Holding Trade Value Shares
Change
Change in
Stake
MP
1
Mangrove Partners
Connecticut
$3.77M +$18.9K +369,289 New
RCM
2
Radcliffe Capital Management
Pennsylvania
$2.05M
LP
3
LMR Partners
United Kingdom
$1.28M +$6.39K +125,000 New
CS
4
Clear Street
New York
$71K +$262 +5,135 +0.7%
PC
5
Periscope Capital
Ontario, Canada
$37.1K +$6.72K +131,500 +18%
SCM
6
Shaolin Capital Management
Florida
$35K
SCM
7
Saba Capital Management
New York
$34.8K
MI
8
MMCAP International
Cayman Islands
$32.5K
AA
9
AQR Arbitrage
Connecticut
$31.2K
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$27.7K
CSS
11
Cubist Systematic Strategies
Connecticut
$26.9K
CF
12
Cantor Fitzgerald
New York
$25K
LA
13
Linden Advisors
New York
$23K
Calamos Advisors
14
Calamos Advisors
Illinois
$23K +$25.6K +500,000 New
QGA
15
Q Global Advisors
Texas
$20K
CAC
16
Cowen and Company
New York
$17.8K +$1.43K +27,895 +19%
TCM
17
Tenor Capital Management
New York
$12.5K
AMH
18
Apollo Management Holdings
New York
$12K
KL
19
KIM LLC
Kansas
$12K
SC
20
Sculptor Capital
New York
$11.5K
WAM
21
Wolverine Asset Management
Illinois
$10.2K
HCM
22
Highbridge Capital Management
New York
$10K
FIG
23
Fortress Investment Group
New York
$9.26K
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$8.18K
TCA
25
Taconic Capital Advisors
New York
$7.5K

BIOSW Hedge Fund Activity: Q4 2022 in Review

44 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q4 2022, worth a combined $7.65M — up 156% from $2.99M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BIOSW and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $25.6K. The largest seller was UBS O'Connor, exiting entirely with an estimated $27K sold.

  • 44 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q4 2022, down from 49 in Q3 2022.
  • Funds reported $7.65M of BioPlus Acquisition Corp. Warrants stock for Q4 2022, up 156% quarter-over-quarter.
  • 3 funds opened new BioPlus Acquisition Corp. Warrants positions in Q4 2022 and 8 closed out, a net change of -5 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q4 2022 was Calamos Advisors, an estimated $25.6K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q4 2022 was UBS O'Connor, an estimated $27K sold.

Based on aggregated 13F filings for Q4 2022.